Cantitate/Preț
Produs

Progress in Drug Research: Progress in Drug Research, cartea 54


en Limba Engleză Paperback – 29 oct 2012
Hypertension is one of the cardiovascular diseases which is most common throughout the world. It is generally defined as an elevation of systolic and/or diastolic arterial blood pressure, which is 120/80 mm Hg in normal situation. A value of 140/90 mm is generally accepted as the upper limit of normotension. Hypertension with certain risk factors such as hypercholes­ terolemia, diabetes, smoking and a family history of vascular disease pre­ disposes to arteriosclerosis and consequent cardiovascular morbidity and mortality. The treatment of hypertension leads to reduced risk of hyperten­ sive renal failure, haemorrhagic stroke, myocardial infarction and cardiac failure. In most cases, the cause of the hypertension can not be clearly defined. Such hypertension is termed as essential hypertension. In a few cases (5- 15%), the hypertension is secondary to definable causes, such as renal artery stenosis, a pheochromocytoma, or an endocrine disorder. This type of hyper­ tension is known as secondary hypertenSion. Although the exact etiology of essential hypertension is still not well known, the following factors are sup­ posed to play causative roles.
Citește tot Restrânge

Din seria Progress in Drug Research

Carte tipărită la comandă

Livrare economică 05-19 iunie


Specificații

ISBN-13: 9783034895460
ISBN-10: 3034895461
Pagini: 324
Ilustrații: VIII, 312 p.
Dimensiuni: 170 x 240 x 18 mm
Greutate: 0.55 kg
Ediția:Softcover reprint of the original 1st ed. 2000
Editura: birkhäuser
Colecția Progress in Drug Research
Seria Progress in Drug Research

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis.- Pharmacology of appetite suppression.- Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.- Neuropeptides in drug research.- Regulation of NMDA receptors by ethanol.- Troglitazone and emerging glitazones: New avenues for potential therapeutic benefits beyond glycemic control.- Applications of developmental biology to medicine and animal agriculture.- Index Vol. 54.- Index of titles, Vol. 1-54.- Author and paper index, Vol. 1-54.